JP2019520059A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520059A5
JP2019520059A5 JP2018561242A JP2018561242A JP2019520059A5 JP 2019520059 A5 JP2019520059 A5 JP 2019520059A5 JP 2018561242 A JP2018561242 A JP 2018561242A JP 2018561242 A JP2018561242 A JP 2018561242A JP 2019520059 A5 JP2019520059 A5 JP 2019520059A5
Authority
JP
Japan
Prior art keywords
peptide
moshiku
cell receptor
cancer
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018561242A
Other languages
English (en)
Japanese (ja)
Other versions
JP7075125B2 (ja
JP2019520059A (ja
Filing date
Publication date
Priority claimed from GBGB1609193.6A external-priority patent/GB201609193D0/en
Application filed filed Critical
Publication of JP2019520059A publication Critical patent/JP2019520059A/ja
Publication of JP2019520059A5 publication Critical patent/JP2019520059A5/ja
Priority to JP2022076519A priority Critical patent/JP2022123887A/ja
Application granted granted Critical
Publication of JP7075125B2 publication Critical patent/JP7075125B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018561242A 2016-05-25 2017-05-23 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ Expired - Fee Related JP7075125B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022076519A JP2022123887A (ja) 2016-05-25 2022-05-06 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662341367P 2016-05-25 2016-05-25
US62/341,367 2016-05-25
GB1609193.6 2016-05-25
GBGB1609193.6A GB201609193D0 (en) 2016-05-25 2016-05-25 Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
PCT/EP2017/062334 WO2017202806A1 (en) 2016-05-25 2017-05-23 Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022076519A Division JP2022123887A (ja) 2016-05-25 2022-05-06 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ

Publications (3)

Publication Number Publication Date
JP2019520059A JP2019520059A (ja) 2019-07-18
JP2019520059A5 true JP2019520059A5 (https=) 2020-05-28
JP7075125B2 JP7075125B2 (ja) 2022-05-25

Family

ID=66329341

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018561242A Expired - Fee Related JP7075125B2 (ja) 2016-05-25 2017-05-23 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ
JP2022076519A Pending JP2022123887A (ja) 2016-05-25 2022-05-06 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022076519A Pending JP2022123887A (ja) 2016-05-25 2022-05-06 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ

Country Status (8)

Country Link
US (3) US10472407B2 (https=)
JP (2) JP7075125B2 (https=)
CL (1) CL2021001525A1 (https=)
IL (1) IL263257A (https=)
MX (1) MX2022000201A (https=)
PH (1) PH12018502315A1 (https=)
TW (1) TW202304969A (https=)
ZA (1) ZA201807333B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7075125B2 (ja) * 2016-05-25 2022-05-25 イマティクス バイオテクノロジーズ ゲーエムベーハー 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061087A2 (en) 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
US20070237770A1 (en) 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
US20050022239A1 (en) 2001-12-13 2005-01-27 Meuleman Petrus Gerardus Recommending media content on a media system
DE10225144A1 (de) 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
WO2005050220A1 (en) * 2003-10-31 2005-06-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 91 (gpr91)
JP2006166789A (ja) 2004-12-15 2006-06-29 Hiroshima Univ 癌の新規診断方法
ES2341802T3 (es) 2005-09-05 2010-06-28 Immatics Biotechnologies Gmbh Peptidos asociados a tumores unidos promiscuamente a moleculas del antigeno de leucocito humano (hla) de clase ii.
CN101168566A (zh) 2006-10-26 2008-04-30 北京市肿瘤防治研究所 抗肿瘤特异性标志蛋白ts/medp的抗体制备及用途
WO2008067195A2 (en) 2006-11-17 2008-06-05 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
PL2565204T3 (pl) 2007-07-27 2016-03-31 Immatics Biotechnologies Gmbh Nowe immunogenne epitopy do immunoterapii
WO2009036246A2 (en) 2007-09-14 2009-03-19 Immunotope, Inc. Immunogens that induce cytotoxic t-lymphocytes and their use in prevention, treatment, and diagnosis of cancer
ME02267B (me) 2008-03-27 2016-04-28 Immatics Biotechnologies Gmbh Nova imunoterapija protiv tumora nervnih ćelija i mozga
JPWO2010110346A1 (ja) * 2009-03-24 2012-10-04 独立行政法人理化学研究所 白血病幹細胞マーカー
WO2012104344A1 (en) 2011-02-01 2012-08-09 Genmab A/S Human antibodies and antibody-drug conjugates against cd74
US9289436B2 (en) 2012-02-24 2016-03-22 The University Of Chicago Method of treatment of prostate cancer with androgen receptor and glucocorticoid receptor antagonists
HK1214652A1 (zh) 2013-03-13 2016-07-29 克里蒂科斯有限责任公司 用於检测胰腺癌的方法和组合物
TWI775117B (zh) 2013-08-05 2022-08-21 德商伊瑪提克斯生物科技有限公司 新穎肽類,細胞及其用於治療多種腫瘤的用途,其製造方法及包含其等之醫藥組成物(二)
GB201319446D0 (en) 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
GB201408255D0 (en) * 2014-05-09 2014-06-25 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
GB201411037D0 (en) 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
AU2015325013B2 (en) 2014-10-01 2021-01-28 PI AgSciences Inc. Hypersensitive response elicitor peptides and use thereof
GB201501017D0 (en) 2014-12-23 2015-03-04 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
GB201504502D0 (en) 2015-03-17 2015-04-29 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
GB201505585D0 (en) 2015-03-31 2015-05-13 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
GB201507030D0 (en) 2015-04-24 2015-06-10 Immatics Biotechnologies Gmbh Immunotherapy against lung cancers, in particular NSCLC
GB201507719D0 (en) 2015-05-06 2015-06-17 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
GB201510771D0 (en) 2015-06-19 2015-08-05 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
GB201511191D0 (en) 2015-06-25 2015-08-12 Immatics Biotechnologies Gmbh T-cell epitopes for the immunotherapy of myeloma
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
GB201511792D0 (en) 2015-07-06 2015-08-19 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
GB201512369D0 (en) 2015-07-15 2015-08-19 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
GB201513921D0 (en) 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
GB201515321D0 (en) 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201517538D0 (en) 2015-10-05 2015-11-18 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
GB201521746D0 (en) 2015-12-10 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
GB201521894D0 (en) 2015-12-11 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various cancers
GB201522667D0 (en) 2015-12-22 2016-02-03 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
GB201602918D0 (en) 2016-02-19 2016-04-06 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
GB201603568D0 (en) 2016-03-01 2016-04-13 Immatics Biotechnologies Gmbh Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
GB201603987D0 (en) 2016-03-08 2016-04-20 Immatics Biotechnologies Gmbh Uterine cancer treatments
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
EA201892159A1 (ru) 2016-04-06 2019-03-29 Имматикс Байотекнолоджиз Гмбх Новые пептиды и комбинации пептидов для применения в иммунотерапии омл и других видов рака
KR20180135481A (ko) 2016-04-21 2018-12-20 이매틱스 바이오테크놀로지스 게엠베하 흑색종 및 기타 암에 대한 면역요법
JP7075125B2 (ja) * 2016-05-25 2022-05-25 イマティクス バイオテクノロジーズ ゲーエムベーハー 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ
DE102017006829B3 (de) 2017-07-19 2018-09-06 Daimler Ag Regalsystem

Similar Documents

Publication Publication Date Title
JP2019516663A5 (https=)
JP2020506690A5 (https=)
JP2019513005A5 (https=)
JP2021101700A5 (https=)
JP2020198875A5 (https=)
JP2020182458A5 (https=)
JP2020191862A5 (https=)
JP2019536426A5 (https=)
JP2024041841A5 (https=)
JP2019502360A5 (https=)
JP2019515653A5 (https=)
JP2020516681A5 (https=)
AR106920A1 (es) Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra la leucemia linfocítica crónica (llc) y otros tipos de cáncer
RU2020113032A (ru) Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака
JP2019520038A5 (https=)
JP2018529320A5 (https=)
AR105817A1 (es) Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de próstata y otros tipos de cáncer
HRP20210698T1 (hr) Peptidi i kombinacija peptida za uporabu u imunoterapiji protiv karcinoma dojke i drugih karcinoma
JP2019511214A5 (https=)
JP2018536383A5 (https=)
JP2021535900A5 (https=)
JP2017525336A5 (https=)
JP2018521641A5 (https=)
JP2018518937A5 (https=)
FI3388075T3 (fi) Uusia peptidejä ja peptidien yhdistelmiä käytettäviksi immunoterapiaan erilaisia syöpiä vastaan